Clinical Trials Browser

Phase 1 × Nanoparticles × 30 days × Clear all

NCT05264974 2026-05-27

Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization

Phase 1 Suspended

DermatologicSarcoma

Melanoma, Sarcoma